Paper39141024
Claims-Based Algorithm to Identify Pre-Exposure Prophylaxis Indications for Tenofovir Disoproxil Fumarate and Emtricitabine Prescriptions (2012-2014): Validation Study.
Sullivan PS and 7 others. JMIR Form Res, 2024. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Claims-Based Algorithm to Identify Pre-Exposure Prophylaxis Indications for Tenofovir Disoproxil Fumarate and Emtricitabine Prescriptions (2012-2014): Validation Study. Papers, record 39141024. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39141024
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Claims-Based Algorithm to Identify Pre-Exposure Prophylaxis Indications for Tenofovir Disoproxil Fumarate and Emtricitabine Prescriptions (2012-2014): Validation Study.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Pre-Exposure Prophylaxis | Major topic |
| Algorithms | Major topic |
| Tenofovir | Major topic |
| Emtricitabine | Major topic |
| HIV Infections | Major topic |
| Humans | |
| Male | |
| Female | |
| Adult | |
| Middle Aged | |
| Anti-HIV Agents | |
| Drug Prescriptions |
Source PubMed
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35678988 | Examining the Correlation Between PrEP Use and Black:White Disparities in HIV Incidence in the Ending the HIV Epidemic Priority Jurisdictions. | J Gen Intern Med | 2023 | https://conductscience.org/library/papers/35678988 | PubMed |
| 2 | 30714945 | Spatial Access and Willingness to Use Pre-Exposure Prophylaxis Among Black/African American Individuals in the United States: Cross-Sectional Survey. | JMIR Public Health Surveill | 2019 | https://conductscience.org/library/papers/30714945 | PubMed |
| 3 | 30730529 | Ending the HIV Epidemic: A Plan for the United States. | JAMA | 2019 | https://conductscience.org/library/papers/30730529 | PubMed |
| 4 | 32711800 | Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial. | Lancet | 2020 | https://conductscience.org/library/papers/32711800 | PubMed |
| 5 | 9595616 | Two-sided confidence intervals for the single proportion: comparison of seven methods. | Stat Med | 1998 | https://conductscience.org/library/papers/9595616 | PubMed |
| 6 | 30335734 | HIV Preexposure Prophylaxis, by Race and Ethnicity - United States, 2014-2016. | MMWR Morb Mortal Wkly Rep | 2018 | https://conductscience.org/library/papers/30335734 | PubMed |
| 7 | 20128015 | Pharmacoepidemiological research using French reimbursement databases: yes we can! | Pharmacoepidemiol Drug Saf | 2010 | https://conductscience.org/library/papers/20128015 | PubMed |
| 8 | 27429893 | Development of a comprehensive measure of spatial access to HIV provider services, with application to Atlanta, Georgia. | Springerplus | 2016 | https://conductscience.org/library/papers/27429893 | PubMed |
| 9 | 30037634 | Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012-2017. | Ann Epidemiol | 2018 | https://conductscience.org/library/papers/30037634 | PubMed |
| 10 | 843571 | The measurement of observer agreement for categorical data. | Biometrics | 1977 | https://conductscience.org/library/papers/843571 | PubMed |
| 11 | 29229440 | Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial. | Lancet Infect Dis | 2018 | https://conductscience.org/library/papers/29229440 | PubMed |
| 12 | 31285182 | Development and validation of an automated HIV prediction algorithm to identify candidates for pre-exposure prophylaxis: a modelling study. | Lancet HIV | 2019 | https://conductscience.org/library/papers/31285182 | PubMed |
| 13 | 32088073 | Methods for county-level estimation of pre-exposure prophylaxis coverage and application to the U.S. Ending the HIV Epidemic jurisdictions. | Ann Epidemiol | 2020 | https://conductscience.org/library/papers/32088073 | PubMed |
| 14 | 23092060 | Interrater reliability: the kappa statistic. | Biochem Med (Zagreb) | 2012 | https://conductscience.org/library/papers/23092060 | PubMed |
| 15 | 32578905 | Using electronic health records to identify candidates for human immunodeficiency virus pre-exposure prophylaxis: An application of super learning to risk prediction when the outcome is rare. | Stat Med | 2020 | https://conductscience.org/library/papers/32578905 | PubMed |
| 16 | 35647866 | Association of Race and Other Social Determinants of Health With HIV Pre-Exposure Prophylaxis Use: A County-Level Analysis Using the PrEP-to-Need Ratio. | AIDS Educ Prev | 2022 | https://conductscience.org/library/papers/35647866 | PubMed |
| 17 | 21091279 | Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. | N Engl J Med | 2010 | https://conductscience.org/library/papers/21091279 | PubMed |
| 18 | 32097453 | Evidence of an Association of Increases in Pre-exposure Prophylaxis Coverage With Decreases in Human Immunodeficiency Virus Diagnosis Rates in the United States, 2012-2016. | Clin Infect Dis | 2020 | https://conductscience.org/library/papers/32097453 | PubMed |
| 19 | 31222499 | Current and Future PrEP Medications and Modalities: On-demand, Injectables, and Topicals. | Curr HIV/AIDS Rep | 2019 | https://conductscience.org/library/papers/31222499 | PubMed |
| 20 | 34379922 | Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women. | N Engl J Med | 2021 | https://conductscience.org/library/papers/34379922 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41617214 | Establish a PrEP (Pre-Exposure Prophylaxis) Epidemiology, Modeling, and Surveillance (PREMISE) System to Analyze Trends in PrEP Uptake and the Impact of PrEP Programs and Policies: Protocol for a Natural Experiment and Modeling Study in the United States. | JMIR Res Protoc | 2026 | https://conductscience.org/library/papers/41617214 | PubMed |
| 41324957 | Telemedicine Preexposure Prophylaxis Prescribing From a Large Online US Company. | JAMA Netw Open | 2025 | https://conductscience.org/library/papers/41324957 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39141024
GET https://conductscience.org/api/papers/v1/39141024/references?page=2